Patents Assigned to HEALTH CLINICS LIMITED
-
Publication number: 20210252024Abstract: A pharmaceutical composition comprising a cancer therapeutic that is capable of inhibiting and/or reducing the ability of a cancer cell to take up and utilize glucose or other energy source, a lipid or other building block of a cell membrane or organelle, and/or cholesterol. The pharmaceutical composition can comprise one or more cancer therapeutics that can be administered individually or in combination to an individual.Type: ApplicationFiled: May 5, 2021Publication date: August 19, 2021Applicant: Health Clinics LimitedInventors: Robin M. Bannister, John Brew, Gregory A. Stoloff
-
Patent number: 11026956Abstract: A pharmaceutical composition comprising a cancer therapeutic that is capable of inhibiting and/or reducing the ability of a cancer cell to take up and utilize glucose or other energy source, a lipid or other building block of a cell membrane or organelle, and/or cholesterol. The pharmaceutical composition can comprise one or more cancer therapeutics that can be administered individually or in combination to an individual.Type: GrantFiled: May 30, 2018Date of Patent: June 8, 2021Assignee: Health Clinics LimitedInventors: Robin M. Bannister, John Brew, Gregory A. Stoloff
-
Patent number: 10188668Abstract: A pharmaceutical composition comprising a cancer therapeutic that is capable of inhibiting and/or reducing the ability of a cancer cell to take up and utilize glucose or other energy source, a lipid or other building block of a cell membrane or organelle, and/or cholesterol. The pharmaceutical composition can comprise one or more cancer therapeutics that can be administered individually or in combination to an individual.Type: GrantFiled: March 6, 2017Date of Patent: January 29, 2019Assignee: Health Clinics LimitedInventors: Robin M. Bannister, John Brew, Gregory A. Stoloff
-
Publication number: 20180271883Abstract: A pharmaceutical composition comprising a cancer therapeutic that is capable of inhibiting and/or reducing the ability of a cancer cell to take up and utilize glucose or other energy source, a lipid or other building block of a cell membrane or organelle, and/or cholesterol. The pharmaceutical composition can comprise one or more cancer therapeutics that can be administered individually or in combination to an individual.Type: ApplicationFiled: May 30, 2018Publication date: September 27, 2018Applicant: Health Clinics LimitedInventors: Robin M. Bannister, John Brew, Gregory A. Stoloff
-
Publication number: 20170189425Abstract: A pharmaceutical composition comprising a cancer therapeutic that is capable of inhibiting and/or reducing the ability of a cancer cell to take up and utilize glucose or other energy source, a lipid or other building block of a cell membrane or organelle, and/or cholesterol. The pharmaceutical composition can comprise one or more cancer therapeutics that can be administered individually or in combination to an individual.Type: ApplicationFiled: March 6, 2017Publication date: July 6, 2017Applicant: Health Clinics LimitedInventors: Robin M. Bannister, John Brew, Gregory A. Stoloff
-
Patent number: 9622982Abstract: A pharmaceutical composition comprising a cancer therapeutic that is capable of inhibiting and/or reducing the ability of a cancer cell to take up and utilize glucose or other energy source, a lipid or other building block of a cell membrane or organelle, and/or cholesterol. The pharmaceutical composition can comprise one or more cancer therapeutics that can be administered individually or in combination to an individual.Type: GrantFiled: January 14, 2014Date of Patent: April 18, 2017Assignee: HEALTH CLINICS LIMITEDInventors: Robin M. Bannister, John Brew, Gregory A. Stoloff